Search Within

Martin Stuart Tallman

  1. "2024"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Department of Pathology and Laboratory Medicine (2)
  6. Biostatistics Service (1)

More Groups

People
  1. Eytan Stein (2)
  2. Aaron Goldberg (1)
  3. Alexander Terry (1)
  4. Andriy Derkach (1)
  5. Christopher Famulare (1)
  6. David Nemirovsky (1)

More People

Years
  1. 2024 (7)
Publications
  1. Blood (4)
  2. Bone Marrow Transplantation (1)
  3. Journal of Clinical Oncology (1)
  4. New England Journal of Medicine (1)
Publishers
  1. American Society of Hematology (4)
  2. American Society of Clinical Oncology (1)
  3. Massachusetts Medical Society (1)
  4. Nature Publishing Group (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genetic risk classification for adults with AML receiving less-intensive therapies: The 2024 ELN recommendations
    Journal Article

    Döhner, H.; DiNardo, C. D.; Appelbaum, F. R.; Craddock, C.; Dombret, H.; Ebert, B. L.; Fenaux, P.; Godley, L. A.; Hasserjian, R. P.; Larson, R. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: Analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
    Journal Article

    Ganzel, C.; Wang, Y.; Roopcharan, K.; Sun, Z.; Rowe, J. M.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
    Journal Article

    Koury, L. C. D. A.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Glória, A. B.; Pagnano, K.; Nunes, E. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults
    Journal Article

    Litzow, M. R.; Sun, Z.; Mattison, R. J.; Paietta, E. M.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Crenolanib and intensive chemotherapy in adults with newly diagnosed FLT3-mutated AML
    Journal Article

    Wang, E. S.; Goldberg, A. D.; Tallman, M.; Walter, R. B.; Karanes, C.; Sandhu, K.; Vigil, C. E.; Collins, R.; Jain, V.; Stone, R. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Ibrutinib-based therapy reinvigorates CD8(+) T cells compared to chemoimmunotherapy: Immune monitoring from the E1912 trial
    Journal Article

    Papazoglou, D.; Wang, X. V.; Shanafelt, T. D.; Lesnick, C. E.; Ioannou, N.; De Rossi, G.; Herter, S.; Bacac, M.; Klein, C.; Tallman, M. S.; more...
    Blood (2024)

    Fulltext@MSK | Save